In this issue:
Long-term cabergoline therapy for macroprolactinomas
Mycophenolate mofetil in moderateto- severe Graves’ orbitopathy
New diagnostic criteria for subclinical hypercortisolism
Antithyroid drug therapy corrects mild neutropenia in Graves’ disease
Long-term impact of growth hormone replacement on QoL
LT4 and pregnancy outcomes in women with autoimmune thyroid disease
Cabergoline for Cushing’s disease
A six-genotype genetic prognostic model for PTC
Significance of unrecognised histological high-risk features in PTC
Please login below to download this issue (PDF)